Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
Status:
Completed
Trial end date:
2010-11-10
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the cognitive enhancing effects and tolerability of GSK239512
compared to placebo in patients with mild to moderate Alzheimer's disease